Aidigong Maternal & Child Health Limited
HKSE 0286.HK
Aidigong Maternal & Child Health Limited EBITDA Margin for the year ending December 31, 2023: 12.41%
-
Aidigong Maternal & Child Health Limited EBITDA Margin for the year ending December 31, 2022 was 8.92%, a -77.77% change year over year.
-
Aidigong Maternal & Child Health Limited EBITDA Margin for the year ending December 31, 2021 was 40.11%, a 252.24% change year over year.
-
Aidigong Maternal & Child Health Limited EBITDA Margin for the year ending December 31, 2020 was -26.35%, a -228.29% change year over year.
-
Aidigong Maternal & Child Health Limited EBITDA Margin for the year ending December 31, 2019 was 20.54%, a 42.18% change year over year.
| Date | EBITDA Margin | EBIT Margin | Depreciation and Amortization | EBIT |
|---|
Don’t Miss A Beat
| CEO | Ms. Aier Wang M.B.A. |
| IPO Date | Sept. 7, 1990 |
| Location | Hong Kong |
| Headquarters | YHC Tower |
| Employees | 1,338 |
| Sector | Consumer Staples |
| Industries | |
Aidigong Maternal & Child Health Limited, an investment holding company, provides postpartum care and healthcare services in the People's Republic of China and Hong Kong. It operates through Postpartum Care Services, Health Industry, and Other segments. The company offers maternal and child healthcare services; medical anti-aging services; healthcare industry investment services; and healthcare property development services, as well as trades in natural health food and pharmaceutical products. It also offers precision life healthcare, bio-medical technology, and management services, as well as investment and finance services. The company was formerly known as Common Splendor International Health Industry Group Limited and changed its name to Aidigong Maternal & Child Health Limited in December 2019. Aidigong Maternal & Child Health Limited is based in Kowloon Bay, Hong Kong.
Past 5 years
USD 0.60
StockViz Staff
February 4, 2025
Any question? Send us an email